Refine
Year of publication
Document Type
- Article (408)
- Preprint (214)
- Contribution to a Periodical (8)
- Conference Proceeding (6)
- Working Paper (6)
- Book (1)
- Report (1)
Has Fulltext
- yes (644)
Is part of the Bibliography
- no (644)
Keywords
- e +-e − Experiments (12)
- BESIII (11)
- Branching fraction (8)
- Particle and Resonance Production (6)
- Charm Physics (5)
- Spectroscopy (5)
- Heavy-ion collisions (4)
- Lepton colliders (4)
- Quarkonium (4)
- portal hypertension (4)
- stochastic differential utility (4)
- COVID-19 (3)
- Charmed mesons (3)
- Diffraction (3)
- Elastic scattering (3)
- Electroweak interaction (3)
- Exotics (3)
- Hadronic decays (3)
- Polarization (3)
- e+-e− Experiments (3)
- Beam Energy Scan (2)
- Biomarkers (2)
- Branching fractions (2)
- Brassica napus (2)
- COVID-19 surveillance (2)
- Cancer (2)
- Charm physics (2)
- Charmonium (2)
- Chiral Magnetic Effect (2)
- Collectivity (2)
- Correlation (2)
- Electroweak Interaction (2)
- Epidemiology (2)
- FBSDE (2)
- Flavour Physics (2)
- Immunology (2)
- Leptonic, semileptonic & radiative decays (2)
- Mechanisms of disease (2)
- Mitochondria (2)
- Non-small cell lung cancer (2)
- Omicron (2)
- Particle decays (2)
- RHIC (2)
- Radiative decay (2)
- Radiotherapy (2)
- Rare diseases (2)
- Registries (2)
- SARS-CoV-2 (2)
- SARS-CoV-2 monitoring (2)
- STAR (2)
- Shear viscosity (2)
- Treatment (2)
- asset pricing (2)
- cirrhosis (2)
- consumption-portfolio choice (2)
- incomplete markets (2)
- microdosing (2)
- recursive utility (2)
- 140Ce (1)
- 3years (1)
- ACLF (1)
- ADGRE1 (1)
- AIS (1)
- ALK (1)
- ALK-rearranged NSCLC (1)
- ARDS (1)
- ATM (1)
- Acuris (1)
- Acute elbow dislocation (1)
- Advanced biliary tract cancer (1)
- Alpha-synuclein (1)
- Alternative oxidase (1)
- Antibiotic therapy (1)
- Antirheumatic agents (1)
- Araneae (1)
- Artificial Intelligence (1)
- Augenerkrankungen (1)
- Autosomal recessive cutis laxa type 1C (1)
- B-slope (1)
- B.1.1.529 (1)
- BA.4 (1)
- BA.5 (1)
- BESIII detector (1)
- BI1361849 (1)
- BTC (1)
- Bacterial leakage (1)
- Beam energy scan (1)
- Bhabha (1)
- Biodiversity Data (1)
- Biogeography (1)
- Biomedical engineering (1)
- Biomonitoring (1)
- Bipolar disorder (1)
- Born cross section (1)
- Born cross section measurement (1)
- Botanical Collections (1)
- Branching fraction measurement (1)
- CAD/CAM crown (1)
- CAKUT (1)
- CBA (1)
- CEP68 (1)
- COMP (1)
- COVID 19 (1)
- CP violation (1)
- CRVO (1)
- CV9202 (1)
- Cardiac implantable electronic devices (1)
- Cardiac rehabilitation (1)
- Cardiac resynchronization therapy (1)
- Cardiovascular disease risk (1)
- Cardiovascular diseases (1)
- Cement gap (1)
- Charged-particle multiplicity (1)
- Charm quark spatial diffusion coefficient (1)
- Charm vector (1)
- Charmonia (1)
- Charmonium (-like) (1)
- Chest pain unit (1)
- Child (1)
- Chiral magnetic effect (1)
- Circadian (1)
- Cirrhosis (1)
- Classification (1)
- Clinical trial (1)
- Coalescence (1)
- Cognitive impairment (1)
- Cohort studies (1)
- Cold nuclear matter effects (1)
- Colorectal cancer (1)
- Comparative effectiveness research (1)
- Complex II (1)
- Concept paper (1)
- Conometric connection (1)
- Consensus (1)
- Consensus document (1)
- Conservation (1)
- Consumption hump (1)
- Coronary intervention (1)
- Critical care (1)
- Critical point (1)
- Cross section (1)
- D meson (1)
- DME (1)
- DNA-PK (1)
- Dark photon (1)
- Dark sector (1)
- Data Standard (1)
- Data protection (1)
- Data sharing (1)
- Datenschutz (1)
- Dermatomyositis (1)
- Detection workflow (1)
- Deuteron production (1)
- Deutschland (1)
- Di-hadron correlations (1)
- Diagnosis (1)
- Digital (1)
- Digitization (1)
- ECM (1)
- EMR1 (1)
- Ecology (1)
- Ecophysiology (1)
- Ectoparasites (1)
- Education (1)
- Effective form factor (1)
- Einwanderer (1)
- Elastogenesis (1)
- Electromagnetic form factor (1)
- Electromagnetic form factors (1)
- Electromagnetic transitions (1)
- Elliptic flow (1)
- Equity (1)
- Etanercept (1)
- Exercise training (1)
- Experimental nuclear physics (1)
- Experimental particle physics (1)
- Extracellular matrix (1)
- Eye diseases (1)
- EyesiNet (1)
- F4/80 (1)
- FOS: Physical sciences (1)
- Fibulin-4 (1)
- Fibulin-5 (1)
- Flavor changing neutral currents (1)
- Flavor symmetries (1)
- Flow (1)
- Form factors (1)
- Forward physics (1)
- Fracture type (1)
- Fremdbild (1)
- GLM (1)
- Genetics (1)
- Genetics research (1)
- Geschichte 1981-1997 (1)
- Gomphus flavipes (1)
- Groomed jet radius (1)
- HCC (1)
- Hadron-Hadron scattering (experiments) (1)
- Hadronization (1)
- Hand-foot syndrome (1)
- Hantavirus (1)
- Health information (1)
- Health-seeking behaviour (1)
- Heart failure (1)
- Heavy Ion Experiments (1)
- Heavy Quark Production (1)
- Heavy ion collisions (1)
- Heavy-Ion Collision (1)
- Heavy-flavor decay electron (1)
- Heavy-ion (1)
- Helicity amplitude analysis (1)
- Helpline (1)
- Herbaria (1)
- Hif1α (1)
- High Energy Physics - Experiment (hep-ex) (1)
- Higher moments (1)
- Hyperons (1)
- Hypertension (1)
- Hypofractionated radiotherapy (1)
- ICU (1)
- IHMCIF (1)
- IL-6 (1)
- ILUVIEN (1)
- IR (1)
- ISS (1)
- Immunogenetics (1)
- Immunomonitoring (1)
- Implantable cardioverter-defibrillator (1)
- Inclusive branching fraction (1)
- Inflammation (1)
- Initial state radiation (1)
- Integrative Modeling (1)
- Interference fragmentation function (1)
- Invisible decays (1)
- J/ψ suppression (1)
- Jet substructure (1)
- K0S (1)
- K3EDTA plasma sampling (1)
- K48-linked (1)
- K63-linked (1)
- Konzeptpapier (1)
- Landscape ecology (1)
- Landschaftsökologie (1)
- Latent transforming growth factor β-binding protein 4 (1)
- Lehre (1)
- Libellen (1)
- Lifestyle (1)
- Lipidomics (1)
- Liver diseases (1)
- Ltbp-4 (1)
- Ltbp-4L (1)
- Ltbp-4S (1)
- L´evy framework (1)
- MACS (1)
- MCP-1 (1)
- MMPs (1)
- MRSA (1)
- MYCN amplification (1)
- Marginal integrity (1)
- Metabolomics (1)
- Microgap (1)
- Mitochondrial disease (1)
- Models & methods for nuclear reactions (1)
- Molecular diagnostic testing (1)
- Molecular medicine (1)
- Multiple parton interactions (1)
- Multivariate analysis (1)
- Myotis myotis (1)
- NAFLD (1)
- NET (1)
- NMDA IgA/IgM antibodies (1)
- NMDA antibody (1)
- NMR spectroscopy (1)
- NSCLC (1)
- NSTEMI (1)
- Net-charge correlations (1)
- Net-charge fluctuations (1)
- Netzhaut (1)
- Neutrinos (1)
- Neutron physics (1)
- Nonflow (1)
- Nuclear reactions (1)
- Nutzen (1)
- Oncogenes (1)
- Open Access (1)
- Ophiogomphus cecilia (1)
- Orphan disease (1)
- Osteoporosis (1)
- Outcome (1)
- Oxidative phosphorylation (1)
- PBSC (1)
- PDB-Dev (1)
- PDBx/mmCIF (1)
- PDE‐5‐inhibitor (1)
- PDGFRβ (1)
- PI3K (1)
- PRRT (1)
- PTEN (1)
- Pacemaker (1)
- Parkinson disease (1)
- Parkinson’s disease (1)
- Particle and resonance production (1)
- Particle phenomena (1)
- Patient safety (1)
- Periodontal disease (1)
- Periodontal therapy (1)
- Pest-crop interactions (1)
- Phalangeal fractures (1)
- Physical activity (1)
- Plasminogen (1)
- Platelets (1)
- Pneumonia (1)
- Portal veins (1)
- Poverty (1)
- Pre-analytics (1)
- Preclinical research (1)
- Predictive markers (1)
- Prevention (1)
- Prognosis (1)
- Prognostic models (1)
- Prostaglandin (1)
- Proton (1)
- Proton-proton collisions (1)
- Proton–proton collisions (1)
- Psychiatric disorders (1)
- Psychiatry (1)
- Puumala virus (1)
- QCD (1)
- Quantum chromodynamics (1)
- RAS pathway (1)
- RNA (1)
- RNA-binding proteins (1)
- Radiative capture (1)
- Rapps (1)
- Rare decays (1)
- Real world (1)
- Register (1)
- Remission (1)
- Research Infrastructure (1)
- Resonance reactions (1)
- Respiratory chain (1)
- Retina (1)
- Retro-IDEAL (1)
- Rh(II) catalysis (1)
- Rheumatoid arthritis (1)
- Rodent-associated infections (1)
- Roosting place (1)
- SARS CoV 2 (1)
- SD-OCT (1)
- SLC20A1 (1)
- SPSS (1)
- STED superresolution (1)
- Sampling protocol (1)
- Schulbuch (1)
- Schädling (1)
- Seasonal variation (1)
- Seltene Erkrankungen (1)
- Semantics (1)
- Semi-leptonic decays (1)
- Single-molecule biophysics (1)
- Social determinants (1)
- SoftDrop (1)
- Solar insolation (1)
- Sorafenib (1)
- Spatial scales (1)
- Spatio-temporal patterns (1)
- Spin alignment (1)
- Spine care (1)
- Spinturnix myoti (1)
- Splitting function (1)
- Standardization (1)
- Staphylococcus aureus (1)
- Stentoplasty (1)
- Steroid (1)
- Student (1)
- Suicide (1)
- Sunlight (1)
- Super-resolution microscopy (1)
- Surgical oncology (1)
- TACE (1)
- TGR(mREN2)27 (1)
- TP53 mutation status (1)
- Taxonomy (1)
- Techniques Electromagnetic calorimeters (1)
- Telemedicine (1)
- Thermal model (1)
- Thoracic trauma (1)
- Threshold effect (1)
- Thrombosis (1)
- Thromboxane (1)
- Transversity (1)
- UWB diagnostics (1)
- VEGF (1)
- VEGFR-2 (1)
- VEGFR-3 (1)
- Variant of concern (1)
- Veins (1)
- Vertebral augmentation (1)
- Vertebral body stenting (1)
- Vertebral fracture (1)
- Vitreous samples (1)
- Wastewater-based epidemiology (WBE) (1)
- Western diet (1)
- Worldwide Protein Data Bank (1)
- X-ray crystallography (1)
- Y states (1)
- accessory proteins (1)
- acute decompensation (1)
- acute myeloid leukemia (1)
- acute-on-chronic liver failure (1)
- adaptive cardiac remodelling (1)
- adverse events (1)
- alternative oxidase (1)
- anaesthesia in orthopaedics (1)
- anaesthetics (1)
- autoantibodies (1)
- azaindole (1)
- backward stochastic differential equation (1)
- bioactivity testing (1)
- bladder exstrophy-epispadias complex (1)
- bleomycin (1)
- bundle (1)
- c-kit (1)
- capture (1)
- cardiac ischaemia‐reperfusion (1)
- cartilage (1)
- cell stress (1)
- cell-free protein synthesis (1)
- center-of-mass energy (1)
- centrosome (1)
- centrosome linker (1)
- cerium (1)
- certainty equivalents (1)
- charmonium-like states (1)
- cloacal malformation (1)
- complications (1)
- computed tomography (1)
- consumption hump (1)
- convergence (1)
- cross-section (1)
- cytarabine dose (1)
- diabetic macular edema (1)
- diazo compounds (1)
- dimuon (1)
- dynamic programming (1)
- e+e − annihilation (1)
- e+e⁻ − Experiments (1)
- e+e− Experiments (1)
- easyPACId (1)
- ectosomes (1)
- education (1)
- elderly (1)
- electron transport chain (1)
- electron-positron collision (1)
- epigeic spiders (1)
- epigäische Spinnen (1)
- erectile dysfunction (1)
- exosomes (1)
- extracellular vesicles (1)
- fibrogenesis (1)
- fixed point approach (1)
- fluocinolone acetonide (1)
- fluorescent dye (1)
- functional genetics (1)
- generalist predators (1)
- generalistische Prädatoren (1)
- geriatric medicine (1)
- global change (1)
- guidelines (1)
- habit formation (1)
- habitat destruction (1)
- hadron spectroscopy (1)
- hadronic events (1)
- health information exchange (1)
- heavy-ion collisions (1)
- helicity amplitude analysis (1)
- hematotoxicity (1)
- hepatic encephalopathy (1)
- hepatic stellate cells (1)
- hepatocellular cancer (1)
- high-risk neuroblastoma (1)
- immunity (1)
- impatience (1)
- in vitro models (1)
- inclusive J/ψ decays (1)
- inflammation (1)
- intrinsically disordered region (1)
- jumps (1)
- kidney formation (1)
- land use (1)
- leisure (1)
- life-cycle utility maximization (1)
- liver (1)
- liver fibrosis (1)
- mRNA active cancer immunotherapy (1)
- macrophage (1)
- metallo β lactamases (1)
- microparticles (1)
- microvesicles (1)
- microwave ablation (1)
- microwave breast imaging (1)
- minimal information requirements (1)
- mouse (1)
- mouse model (1)
- multiresistant bacteria (1)
- n_TOF (1)
- natural products (1)
- nematophin (1)
- neuroendocrine tumor (1)
- neutralizing antibodies (1)
- neutron (1)
- nonstructural proteins (1)
- non‐selective beta‐blocker (1)
- normalization (1)
- nucleosynthesis (1)
- number of J/ψ events (1)
- optimal investment (1)
- osteoarthritis (1)
- oval split ring resonator (1)
- p+p collisions (1)
- p53 pathway (1)
- patient study (1)
- peptide receptor radionuclide therapy (1)
- peripheral blood stem cell collection (1)
- polyubiquitin (1)
- portosystemic shunt (1)
- prevention (1)
- primary biliary cholangitis (1)
- proteobacteria (1)
- qualitative research (1)
- quality control (1)
- rare diseases (1)
- reactive oxygen species (1)
- renin-angiotensin system (1)
- reproducibility (1)
- resectability (1)
- rigor (1)
- rootletin (1)
- s-process (1)
- second line therapy (1)
- sequential ALK-inhibitor therapy (1)
- simplified production (1)
- sorafenib (1)
- sphingolipid sphingosine-1-phosphate (1)
- sphingolipids (1)
- sphingosine-1-phosphate receptor 5 (1)
- spike protein (1)
- spontaneous portosystemic shunt (1)
- standardization (1)
- steatosis (1)
- stochastic volatility (1)
- structural proteins (1)
- surgery (1)
- systemic sclerosis (1)
- tetraquark (1)
- theranostics (1)
- thiol inhibitors (1)
- thrombospondins (1)
- treatment (1)
- treatment response (1)
- trigger efficiency (1)
- ubiquitin-conjugating enzymes (1)
- urinary tract development (1)
- ursodeoxycholic acid (1)
- variant of concern (1)
- variants of concern (1)
- wage hump (1)
- wastewater-based epidemiology (WBE) (1)
- welfare loss (1)
- wwPDB (1)
- zebrafish development (1)
- Λ+c baryon (1)
- Σ hyperon (1)
- Υ suppression (1)
- ψ(3686) (1)
- fibrogenesis (1)
Institute
- Physik (374)
- Frankfurt Institute for Advanced Studies (FIAS) (106)
- Medizin (91)
- Geowissenschaften (23)
- Präsidium (8)
- Biochemie und Chemie (7)
- Biochemie, Chemie und Pharmazie (7)
- Biowissenschaften (7)
- Wirtschaftswissenschaften (7)
- Center for Financial Studies (CFS) (6)
Purpose: To evaluate the efficacy of the virtual reality training simulator Eyesi to prepare surgeons for performing pars plana vitrectomies and its potential to predict the surgeons’ performance.
Methods: In a preparation phase, four participating vitreoretinal surgeons performed repeated simulator training with predefined tasks. If a surgeon was assigned to perform a vitrectomy for the management of complex retinal detachment after a surgical break of at least 60 hours it was randomly decided whether a warmup training on the simulator was required (n = 9) or not (n = 12). Performance at the simulator was measured using the built-in scoring metrics. The surgical performance was determined by two blinded observers who analyzed the video-recorded interventions. One of them repeated the analysis to check for intra-observer consistency. The surgical performance of the interventions with and without simulator training was compared. In addition, for the surgeries with simulator training, the simulator performance was compared to the performance in the operating room.
Results: Comparing each surgeon’s performance with and without warmup trainingshowed a significant effect of warmup training onto the final outcome in the operating room. For the surgeries that were preceeded by the warmup procedure, the performance at the simulator was compared with the operating room performance. We found that there is a significant relation. The governing factor of low scores in the simulator were iatrogenic retinal holes, bleedings and lens damage. Surgeons who caused minor damage in the simulation also performed well in the operating room.
Conclusions: Despite the large variation of conditions, the effect of a warmup training as well as a relation between the performance at the simulator and in the operating room was found with statistical significance. Simulator training is able to serve as a warmup to increase the average performance.
Purpose: There are little or no published data comparing the outcomes of ILUVIEN® (0.19 mg fluocinolone acetonide [FAc]) and OZURDEX® (0.7 mg dexamethasone [DEX]) implants in patients with diabetic macular edema (DME), and this case sought to compare their outcomes.
Methods: This case was extracted from a monocentric audit involving a pool of 25 patients (33 eyes) with DME and treated with a single FAc implant between October 2013 and December 2016. This case, a 61-year-old male with a pseudophakic lens, is from a patient that had received 4 intravitreal injections of a DEX implant prior to FAc implant and then was monitored for 3 years until re-treatment with a second FAc implant. Parameters measured included visual acuity (VA), central retinal thickness (CRT), and intraocular pressure (IOP).
Results: After the DEX implants, CRT transiently improved. In March 2014, the decision was taken to administer an FAc implant, and this led to a reduction in CRT below 300 µm (from a baseline of 748 µm), and this was sustained for 30 months. VA remained above 65 Early Treatment Diabetic Retinopathy Study letters to month 36, after which time a second FAc implant (in April 2017) was administered due to recurrence of edema and CRT decreased to below 300 µm and VA improved to 70 letters. Side effects included elevated IOP, which was effectively managed with IOP-lowering drops.
Conclusion: A single injection of FAc implant led to sustained improvements in CRT and VA that lasted for between 30 and 36 months, which is in contrast to the DEX implant where re-treatment was generally required within 6–7 months. After 36 months, re-treatment with the FAc implant again led to improved VA and CRT, and responses that were similar to those achieved with the first FAc implant.
Objectives: An increasing number of treatment-determining biomarkers has been identified in non-small cell lung cancer (NSCLC) and molecular testing is recommended to enable optimal individualized treatment. However, data on implementation of these recommendations in the “real-world” setting are scarce. This study presents comprehensive details on the frequency, methodology and results of biomarker testing of advanced NSCLC in Germany.
Patients and methods: This analysis included 3,717 patients with advanced NSCLC (2,921 non-squamous; 796 squamous), recruited into the CRISP registry at start of systemic therapy by 150 German sites between December 2015 and June 2019. Evaluated were the molecular biomarkers EGFR, ALK, ROS1, BRAF, KRAS, MET, TP53, RET, HER2, as well as expression of PD-L1.
Results: In total, 90.5 % of the patients were tested for biomarkers. Testing rates were 92.2 % (non-squamous), 70.7 % (squamous) and increased from 83.2 % in 2015/16 to 94.2% in 2019. Overall testing rates for EGFR, ALK, ROS1, and BRAF were 72.5 %, 74.5 %, 66.1 %, and 53.0 %, respectively (non-squamous). Testing rates for PD-L1 expression were 64.5 % (non-squamous), and 58.5 % (squamous). The most common testing methods were immunohistochemistry (68.5 % non-squamous, 58.3 % squamous), and next-generation sequencing (38.7 % non-squamous, 14.4 % squamous). Reasons for not testing were insufficient tumor material or lack of guideline recommendations (squamous). No alteration was found in 37.8 % (non-squamous), and 57.9 % (squamous), respectively. Most common alterations in non-squamous tumors (all patients/all patients tested for the respective biomarker): KRAS (17.3 %/39.2 %), TP53 (14.1 %/51.4 %), and EGFR (11.0 %/15.1 %); in squamous tumors: TP53 (7.0 %/69.1 %), MET (1.5 %/11.1 %), and EGFR (1.1 %/4.4 %). Median PFS (non-squamous) was 8.7 months (95 % CI 7.4–10.4) with druggable EGFR mutation, and 8.0 months (95 % CI 3.9–9.2) with druggable ALK alterations.
Conclusion: Testing rates in Germany are high nationwide and acceptable in international comparison, but still leave out a significant portion of patients, who could potentially benefit. Thus, specific measures are needed to increase implementation.
Cardiac rehabilitation (CR) is a multidisciplinary intervention including patient assessment and medical actions to promote stabilization, management of cardiovascular risk factors, vocational support, psychosocial management, physical activity counselling, and prescription of exercise training. Millions of people with cardiac implantable electronic devices live in Europe and their numbers are progressively increasing, therefore, large subsets of patients admitted in CR facilities have a cardiac implantable electronic device. Patients who are cardiac implantable electronic devices recipients are considered eligible for a CR programme. This is not only related to the underlying heart disease but also to specific issues, such as psychological adaptation to living with an implanted device and, in implantable cardioverter-defibrillator patients, the risk of arrhythmia, syncope, and sudden cardiac death. Therefore, these patients should receive special attention, as their needs may differ from other patients participating in CR. As evidence from studies of CR in patients with cardiac implantable electronic devices is sparse, detailed clinical practice guidelines are lacking. Here, we aim to provide practical recommendations for CR in cardiac implantable electronic devices recipients in order to increase CR implementation, efficacy, and safety in this subset of patients.
Systemic inflammation is associated with alterations in complex brain functions such as learning and memory. However, diagnostic approaches to functionally assess and quantify inflammation-associated alterations in synaptic plasticity are not well-established. In previous work, we demonstrated that bacterial lipopolysaccharide (LPS)-induced systemic inflammation alters the ability of hippocampal neurons to express synaptic plasticity, i.e., the long-term potentiation (LTP) of excitatory neurotransmission. Here, we tested whether synaptic plasticity induced by repetitive magnetic stimulation (rMS), a non-invasive brain stimulation technique used in clinical practice, is affected by LPS-induced inflammation. Specifically, we explored brain tissue cultures to learn more about the direct effects of LPS on neural tissue, and we tested for the plasticity-restoring effects of the anti-inflammatory cytokine interleukin 10 (IL10). As shown previously, 10 Hz repetitive magnetic stimulation (rMS) of organotypic entorhino-hippocampal tissue cultures induced a robust increase in excitatory neurotransmission onto CA1 pyramidal neurons. Furthermore, LPS-treated tissue cultures did not express rMS-induced synaptic plasticity. Live-cell microscopy in tissue cultures prepared from a novel transgenic reporter mouse line [C57BL/6-Tg(TNFa-eGFP)] confirms that ex vivo LPS administration triggers microglial tumor necrosis factor alpha (TNFα) expression, which is ameliorated in the presence of IL10. Consistent with this observation, IL10 hampers the LPS-induced increase in TNFα, IL6, IL1β, and IFNγ and restores the ability of neurons to express rMS-induced synaptic plasticity in the presence of LPS. These findings establish organotypic tissue cultures as a suitable model for studying inflammation-induced alterations in synaptic plasticity, thus providing a biological basis for the diagnostic use of transcranial magnetic stimulation in the context of brain inflammation.
On the robustness of the r-process in neutron-star mergers against variations of nuclear masses
(2016)
r-process calculations have been performed for matter ejected dynamically in neutron star mergers (NSM), such calculations are based on a complete set of trajectories from a three-dimensional relativistic smoothed particle hydrodynamic (SPH) simulation. Our calculations consider an extended nuclear reaction network, including spontaneous, β- and neutron-induced fission and adopting fission yield distributions from the ABLA code. In this contribution we have studied the sensitivity of the r-process abundances to nuclear masses by using diferent mass models for the calculation of neutron capture cross sections via the statistical model. Most of the trajectories, corresponding to 90% of the ejected mass, follow a relatively slow expansion allowing for all neutrons to be captured. The resulting abundances are very similar to each other and reproduce the general features of the observed r-process abundance (the second and third peaks, the rare-earth peak and the lead peak) for all mass models as they are mainly determined by the fission yields. We find distinct differences in the predictions of the mass models at and just above the third peak, which can be traced back to different predictions of neutron separation energies for r-process nuclei around neutron number N = 130.
Background & Aims: Phosphodiesterase‐5 inhibitors (PDE‐5‐I) are used for treatment of erectile dysfunction (ED), which is common in patients with cirrhosis. They may improve portal hypertension (PH), but contradictory data on efficacy and side‐effects have been reported. Non‐selective beta blockers (NSBB) reduce portal pressure, but might aggravate ED. Thus, we evaluated the combination of PDE‐5‐I with NSBB and its impact on PH and ED in experimental cirrhosis.
Methods: ED was assessed in cirrhotic patients (n = 86) using standardized questionnaire. Experimental cirrhosis was induced by bile‐duct‐ligation or carbon‐tetrachloride intoxication in rats. Corpus cavernosum pressure – a surrogate of ED ‐, as well as systemic and portal haemodynamics, were measured in vivo and in situ after acute administration of udenafil alone or in combination with propranolol. mRNA and protein levels of PDE‐5 signalling were analysed using PCR and western Blot.
Results: ED in humans was related to severity of liver disease and to NSBB treatment. PDE‐5 was mainly expressed in hepatic stellate cells and upregulated in human and experimental cirrhosis. Propranolol reduced corpus cavernosum pressure in cirrhotic rats and it was restored by udenafil. Even though udenafil treatment improved PH, it led to a reduction of mean arterial pressure. The combination of udenafil and propranolol reduced portal pressure and hepatic resistance without systemic side‐effects.
Conclusions: ED is common with advanced cirrhosis and concomitant NSBB treatment. The combination of PDE‐5‐I and NSBB improves ED and PH in experimental cirrhosis.
Introduction: Recent animal studies have shown that the alternate renin-angiotensin system (RAS) consisting of angiotensin-converting enzyme 2 (ACE2), angiotensin-(1–7) (Ang-(1–7)) and the Mas receptor is upregulated in cirrhosis and contributes to splanchnic vasodilatation and portal hypertension. To determine the potential relevance of these findings to human liver disease, we evaluated its expression and relationship to the patients’ clinical status in subjects with cirrhosis. Methods: Blood sampling from peripheral and central vascular beds was performed intra-operatively for cirrhotic patients at the time of liver transplantation (LT) or trans-jugular intra-hepatic portosystemic shunt (TIPS) procedures to measure angiotensin II (Ang II) and Ang-(1–7) peptide levels and ACE and ACE2 enzyme activity. Relevant clinical and hemodynamic data were recorded pre-operatively for all subjects and peripheral blood sampling was repeated 3 months or later post-operatively. Results: Ang-(1–-7) and ACE2 activity were up-regulated more than twofold in cirrhotic subjects both at the time of LT and TIPS and levels returned to comparable levels as control subjects post-transplantation. Ang-(1–7) levels correlated positively with the degree of liver disease severity, as measured by the model for an end-stage liver disease (MELD) and also with clinical parameters of pathological vasodilatation including cardiac output (CO). There were strong correlations found between the ACE2:ACE and the Ang-(1–7):Ang II ratio highlighting the inter-dependence of the alternate and classical arms of the RAS and thus their potential impact on vascular tone. Conclusions: In human cirrhosis, the alternate RAS is markedly upregulated and the activation of this system is associated strongly with features of the hyperdynamic circulation in advanced human cirrhosis.
Non-alcoholic fatty liver disease (NAFLD) is gaining in importance and is linked to obesity. Especially,thedevelopmentoffibrosisandportalhypertensioninNAFLDpatientsrequirestreatment. Transgenic TGR(mREN2)27 rats overexpressing mouse renin spontaneously develop NAFLD with portal hypertension but without obesity. This study investigated the additional role of obesity in this model on the development of portal hypertension and fibrosis. Obesity was induced in twelve-week old TGR(mREN2)27 rats after receiving Western diet (WD) for two or four weeks. Liver fibrosis was assessed using standard techniques. Hepatic expression of transforming growth factor-β1 (TGF-β1), collagen type Iα1, α-smooth muscle actin, and the macrophage markers Emr1, as well as the chemoattractant Ccl2, interleukin-1β (IL1β) and tumor necrosis factor-α (TNFα) were analyzed. Assessment of portal and systemic hemodynamics was performed using the colored microsphere technique. Asexpected,WDinducedobesityandliverfibrosisasconfirmedbySiriusRedandOilRed O staining. The expression of the monocyte-macrophage markers, Emr1, Ccl2, IL1β and TNFα were increasedduringfeedingofWD,indicatinginfiltrationofmacrophagesintotheliver,eventhoughthis increase was statistically not significant for the EGF module-containing mucin-like receptor (Emr1) mRNA expression levels. Of note, portal pressure increased with the duration of WD compared to animals that received a normal chow. Besides obesity, WD feeding increased systemic vascular resistance reflecting systemic endothelial and splanchnic vascular dysfunction. We conclude that transgenic TGR(mREN2)27 rats are a suitable model to investigate NAFLD development with liver fibrosis and portal hypertension. Tendency towards elevated expression of Emr1 is associated with macrophage activity point to a significant role of macrophages in NAFLD pathogenesis, probably due to a shift of the renin–angiotensin system towards a higher activation of the classical pathway. The hepatic injury induced by WD in TGR(mREN2)27 rats is suitable to evaluate different stages of fibrosis and portal hypertension in NAFLD with obesity.
Prevalence of non-alcoholic fatty liver disease (NAFLD) is increasing. Resulting fibrosis and portal hypertension, as a possible secondary event, may necessitate treatment. Overexpression of mouse renin in the transgenic rat model, TGR(mREN2)27, leads to spontaneous development of NAFLD. Therefore, we used TGR(mREN2)27 rats as a model of NAFLD where we hypothesized increased susceptibility and investigated fibrosis and portal hypertension and associated pathways. 12-week old TGR(mREN2)27 rats received either cholestatic (BDL) or toxic injury (CCl4 inhalation). Portal and systemic hemodynamic assessments were performed using microsphere technique with and without injection of the Janus-Kinase 2 (JAK2) inhibitor AG490 or the non-peptidic Ang(1-7) agonist, AVE0991. The extent of liver fibrosis was assessed in TGR(mREN2)27 and wild-type rats using standard techniques. Protein and mRNA levels of profibrotic, renin-angiotensin system components were assessed in liver and primary hepatic stellate cells (HSC) and hepatocytes. TGR(mREN2)27 rats developed spontaneous, but mild fibrosis and portal hypertension due to the activation of the JAK2/Arhgef1/ROCK pathway. AG490 decreased migration of HSC and portal pressure in isolated liver perfusions and in vivo. Fibrosis or portal hypertension after cholestatic (BDL) or toxic injury (CCl4) was not aggravated in TGR(mREN2)27 rats, probably due to decreased mouse renin expression in hepatocytes. Interestingly, portal hypertension was even blunted in TGR(mREN2)27 rats (with or without additional injury) by AVE0991. TGR(mREN2)27 rats are a suitable model of spontaneous liver fibrosis and portal hypertension but not with increased susceptibility to liver damage. After additional injury, the animals can be used to evaluate novel therapeutic strategies targeting Mas.
The transcription factor Meis1 drives myeloid leukemogenesis in the context of Hox gene overexpression but is currently considered undruggable. We therefore investigated whether myeloid progenitor cells transformed by Hoxa9 and Meis1 become addicted to targetable signaling pathways. A comprehensive (phospho)proteomic analysis revealed that Meis1 increased Syk protein expression and activity. Syk upregulation occurs through a Meis1-dependent feedback loop. By dissecting this loop, we show that Syk is a direct target of miR-146a, whose expression is indirectly regulated by Meis1 through the transcription factor PU.1. In the context of Hoxa9 overexpression, Syk signaling induces Meis1, recapitulating several leukemogenic features of Hoxa9/Meis1-driven leukemia. Finally, Syk inhibition disrupts the identified regulatory loop, prolonging survival of mice with Hoxa9/Meis1-driven leukemia.
Introns of human transfer RNA precursors (pre-tRNAs) are excised by the tRNA splicing endonuclease TSEN in complex with the RNA kinase CLP1. Mutations in TSEN/CLP1 occur in patients with pontocerebellar hypoplasia (PCH), however, their role in the disease is unclear. Here, we show that intron excision is catalyzed by tetrameric TSEN assembled from inactive heterodimers independently of CLP1. Splice site recognition involves the mature domain and the anticodon-intron base pair of pre-tRNAs. The 2.1-Å resolution X-ray crystal structure of a TSEN15–34 heterodimer and differential scanning fluorimetry analyses show that PCH mutations cause thermal destabilization. While endonuclease activity in recombinant mutant TSEN is unaltered, we observe assembly defects and reduced pre-tRNA cleavage activity resulting in an imbalanced pre-tRNA pool in PCH patient-derived fibroblasts. Our work defines the molecular principles of intron excision in humans and provides evidence that modulation of TSEN stability may contribute to PCH phenotypes.
The HITRAP linear decelerator currently being set up at GSI will provide slow, few keV/u highly charged ions for atomic physics experiments. The expected beam intensity is up to 105 ions per shot. To optimize phase and amplitude of the RF systems intensity, bunch length and kinetic energy of the particles need to be monitored. The bunch length that we need to fit is about 2 ns, which is typically measured by capacitive pickups. However, they do not work for the low beam intensities that we face. We investigated the bunch length with a fast CVD diamond detector working in single particle counting mode. Averaging over 8 shots yields a clear, regular picture of the bunched beam. Energy measurements by capacitive pickups are limited by the presence of intense primary and partially decelerated beam and hence make tuning of the IH-structure impossible. The energy of the decelerated fraction of the beam behind the first deceleration cavity was determined to about 10 % accuracy with a permanent dipole magnet combined with a MCP. Better detector calibration should help reaching the required 1%. Design of the detectors as well as the results of the measurements will be presented.
Background: Preclinical studies demonstrate synergism between cancer immunotherapy and local radiation, enhancing anti-tumor effects and promoting immune responses. BI1361849 (CV9202) is an active cancer immunotherapeutic comprising protamine-formulated, sequence-optimized mRNA encoding six non-small cell lung cancer (NSCLC)-associated antigens (NY-ESO-1, MAGE-C1, MAGE-C2, survivin, 5T4, and MUC-1), intended to induce targeted immune responses.
Methods: We describe a phase Ib clinical trial evaluating treatment with BI1361849 combined with local radiation in 26 stage IV NSCLC patients with partial response (PR)/stable disease (SD) after standard first-line therapy. Patients were stratified into three strata (1: non-squamous NSCLC, no epidermal growth factor receptor (EGFR) mutation, PR/SD after ≥4 cycles of platinum- and pemetrexed-based treatment [n = 16]; 2: squamous NSCLC, PR/SD after ≥4 cycles of platinum-based and non-platinum compound treatment [n = 8]; 3: non-squamous NSCLC, EGFR mutation, PR/SD after ≥3 and ≤ 6 months EGFR-tyrosine kinase inhibitor (TKI) treatment [n = 2]). Patients received intradermal BI1361849, local radiation (4 × 5 Gy), then BI1361849 until disease progression. Strata 1 and 3 also had maintenance pemetrexed or continued EGFR-TKI therapy, respectively. The primary endpoint was evaluation of safety; secondary objectives included assessment of clinical efficacy (every 6 weeks during treatment) and of immune response (on Days 1 [baseline], 19 and 61).
Results: Study treatment was well tolerated; injection site reactions and flu-like symptoms were the most common BI1361849-related adverse events. Three patients had grade 3 BI1361849-related adverse events (fatigue, pyrexia); there was one grade 3 radiation-related event (dysphagia). In comparison to baseline, immunomonitoring revealed increased BI1361849 antigen-specific immune responses in the majority of patients (84%), whereby antigen-specific antibody levels were increased in 80% and functional T cells in 40% of patients, and involvement of multiple antigen specificities was evident in 52% of patients. One patient had a partial response in combination with pemetrexed maintenance, and 46.2% achieved stable disease as best overall response. Best overall response was SD in 57.7% for target lesions.
Conclusion: The results support further investigation of mRNA-based immunotherapy in NSCLC including combinations with immune checkpoint inhibitors.
Trial registration: ClinicalTrials.gov identifier: NCT01915524.
Broad AOX expression in a genetically tractable mouse model does not disturb normal physiology
(2017)
Plants and many lower organisms, but not mammals, express alternative oxidases (AOXs) that branch the mitochondrial respiratory chain, transferring electrons directly from ubiquinol to oxygen without proton pumping. Thus, they maintain electron flow under conditions when the classical respiratory chain is impaired, limiting excess production of oxygen radicals and supporting redox and metabolic homeostasis. AOX from Ciona intestinalis has been used to study and mitigate mitochondrial impairments in mammalian cell lines, Drosophila disease models and, most recently, in the mouse, where multiple lentivector-AOX transgenes conferred substantial expression in specific tissues. Here, we describe a genetically tractable mouse model in which Ciona AOX has been targeted to the Rosa26 locus for ubiquitous expression. The AOXRosa26 mouse exhibited only subtle phenotypic effects on respiratory complex formation, oxygen consumption or the global metabolome, and showed an essentially normal physiology. AOX conferred robust resistance to inhibitors of the respiratory chain in organello; moreover, animals exposed to a systemically applied LD50 dose of cyanide did not succumb. The AOXRosa26 mouse is a useful tool to investigate respiratory control mechanisms and to decipher mitochondrial disease aetiology in vivo.
Objectives: A conometric concept was recently introduced in which conical implant abutments hold the matching crown copings by friction alone, eliminating the need for cement or screws. The aim of this in vitro study was to assess the presence of microgap formation and bacterial leakage at the Acuris conometric restorative interface of three different implant abutment systems. Material and methods: A total of 75 Acuris samples of three implant-abutment systems (Ankylos, Astra Tech EV, Xive) were subjected to microbiological (n = 60) and scanning electron microscopic (SEM) investigation (n = 15). Bacterial migration into and out of the conical coupling system were analyzed in an anaerobic workstation for 48, 96, 144, and 192 h. Bacterial DNA quantification using qrt-PCR was performed at each time point. The precision of the conometric coupling and internal fit of cemented CAD/CAM crowns on corresponding Acuris TiN copings were determined by means of SEM. Results: qrt-PCR results failed to demonstrate microbial leakage from or into the Acuris system. SEM analysis revealed minute punctate microgaps at the apical aspect of the conometric junction (2.04 to 2.64 µm), while mean cement gaps of 12 to 145 µm were observed at the crown-coping interface. Conclusions: The prosthetic morse taper connection of all systems examined does not allow bacterial passage. Marginal integrity and internal luting gap between the ceramic crown and the coping remained within the clinically acceptable limits. Clinical relevance: Conometrically seated single crowns provide sufficient sealing efficiency, relocating potential misfits from the crown-abutment interface to the crown-coping interface.
Activation of Mitochondrial complex II-dependent respiration is beneficial for α-Synucleinopathies
(2015)
Parkinson’s disease and dementia with Lewy bodies are major challenges in research and clinical medicine world-wide and contribute to the most common neurodegenerative disorders. Previously, specific mitochondrial polymorphisms have been found to enhance clearance of amyloid-β from the brain of APP-transgenic mice leading to beneficial clinical outcome. It has been discussed whether specific mitochondrial alterations contribute to disease progression or even prevent toxic peptide deposition, as seen in many neurodegenerative diseases. Here, we investigated α-synuclein-transgenic C57BL/6J mice with the A30P mutation, and a novel A30P C57BL/6J mouse model with three mitochondrial DNA polymorphisms in the ND3, COX3 and mtRNAArg genes, as found in the inbred NOD/LtJ mouse strain. We were able to detect that the new model has increased mitochondrial complex II-respiration which occurs in parallel to neuronal loss and improved motor performance, although it exhibits higher amounts of high molecular weight species of α-synuclein. High molecular weight aggregates of different peptides are controversially discussed in the light of neurodegeneration. A favourable hypothesis states that high molecular weight species are protective and of minor importance for the pathogenesis of neurodegenerative disorders as compared to the extreme neurotoxic monomers and oligomers. Summarising, our results point to a potentially protective and beneficial effect of specific mitochondrial polymorphisms which cause improved mitochondrial complex II-respiration in α-synucleinopathies, an effect that could be exploited further for pharmaceutical interventions.
Although the 12C(n,p)12B and 12C(n,d)11B reactions are of interest in several fields of basic and applied Nuclear Physics the present knowledge of these two cross-sections is far from being accurate and reliable, with both evaluations and data showing sizable discrepancies. As part of the challenging n_TOF program on (n,cp) nuclear reactions study, the energy differential cross-sections of the 12C(n,p)12B and 12C(n,d)11 B reactions have been measured at CERN from the reaction thresholds up to 30 MeV neutron energy. Both measurements have been recently performed at the long flight-path (185 m) experimental area of the n_TOF facility at CERN using a pure (99.95%) rigid graphite target and two silicon telescopes. In this paper an overview of the experiment is presented together with a few preliminary results.
Introns of human transfer RNA precursors (pre-tRNAs) are excised by the tRNA splicing endonuclease TSEN in complex with the RNA kinase CLP1. Mutations in TSEN/CLP1 occur in patients with pontocerebellar hypoplasia (PCH), however, their role in the disease is unclear. Here, we show that intron excision is catalyzed by tetrameric TSEN assembled from inactive heterodimers independently of CLP1. Splice site recognition involves the mature domain and the anticodon-intron base pair of pre-tRNAs. The 2.1-Å resolution X-ray crystal structure of a TSEN15–34 heterodimer and differential scanning fluorimetry analyses show that PCH mutations cause thermal destabilization. While endonuclease activity in recombinant mutant TSEN is unaltered, we observe assembly defects and reduced pre-tRNA cleavage activity resulting in an imbalanced pre-tRNA pool in PCH patient-derived fibroblasts. Our work defines the molecular principles of intron excision in humans and provides evidence that modulation of TSEN stability may contribute to PCH phenotypes.